Tuesday, 06 February 2024
ICN2 Researchers Develop a Novel and Low-Cost Platform for the Rapid Detection of COVID-19 Genes
Researchers from the Nanobioelectronics and Biosensors group at ICN2 have developed a platform to detect two SARS-CoV-2 genes simultaneously, using inkjet-printed nanostructured gold electrodes and a battery-free NFC potentiostat. This platform offers speed, simplicity, sensitivity, and cost-effectiveness, making it a promising solution for point-of-care diagnostics and high-throughput analysis.
![](/images/NEWS_2024/Fig_11.jpg)